1. Genome-wide miRNA profiling in plasma of pregnant women with down syndrome fetuses
- Author
-
Aleš Hořínek, Ondřej Šeda, Eva Pazourkova, Iveta Zednikova, Miroslava Krkavcová, Blanka Chylíková, Pavel Calda, Marie Korabecna, and Miroslav Břešťák
- Subjects
0301 basic medicine ,Adult ,Down syndrome ,Validation study ,Trisomy 21 ,Gene Expression ,Pilot Projects ,Biology ,Real-Time Polymerase Chain Reaction ,Genome ,Andrology ,03 medical and health sciences ,Plasma ,0302 clinical medicine ,Fetus ,Pregnancy ,Prenatal Diagnosis ,microRNA ,Genetics ,medicine ,Fetal aneuploidy ,Mirna profiling ,Humans ,Liquid biopsy ,Molecular Biology ,miRNA ,Oligonucleotide Array Sequence Analysis ,Gene Expression Profiling ,General Medicine ,medicine.disease ,MicroRNAs ,Pregnancy Trimester, First ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Chorionic villi ,Original Article ,Female ,Pregnant Women ,Transcriptome ,NIPT ,Genome-Wide Association Study - Abstract
Down syndrome (DS) is one of the most common causes of intellectual disability and new approaches allowing its rapid and effective prenatal detection are being explored. In this study, we investigated the diagnostic potential of plasma microRNAs (miRNAs). This study builds upon our previous study in DS placentas, where seven miRNAs were found to be significantly up-regulated. A total of 70 first-trimester plasma samples from pregnant women were included in the present study (35 samples with DS fetuses; 35 with euploid fetuses). Genome-wide miRNA profiling was performed in the pilot study using Affymetrix GeneChip™ miRNA 4.1 Array Strips (18 samples). Selected miRNAs were then analysed in the validation study using quantitative reverse transcription PCR (RT-qPCR; 52 samples). Based on the current pilot study results (12 miRNAs), our previous research on chorionic villi samples (7 miRNAs) and the literature (4 miRNAs), a group of 23 miRNAs was selected for the validation study. Although the results of the pilot study were promising, the validation study using the more sensitive RT-qPCR technique and a larger group of samples revealed no significant differences in miRNA profiles between the compared groups. Our results suggest that testing of the first-trimester plasma miRNAs is probably not suitable for non-invasive prenatal testing (NIPT). Different results could be theoretically achieved at later gestational ages; however, such a result probably would have limited use in clinical practice. Electronic supplementary material The online version of this article (10.1007/s11033-020-05545-w) contains supplementary material, which is available to authorized users.
- Published
- 2020